PCROWD NEWS

See the Story on Katie Couric's Website here. Katie Couric has spent many years advocating for patients with cancer. In a recent...

Tom Brokaw was diagnosed with Multiple Myeloma (MM) in 2013. Since then, he's made it his mission to raise awareness about MM and support...

Welcome to a 3-part series for patients living with blood cancer or its precursor conditions, and their families, including those...

Listen in to our physicians' discussion on the impacts of COVID-19 on multiple myeloma and precursor condition treatment plans,...

The patient support discussion will be based around importance of early cancer screening for people at risk, health disparities in...

Our team publishes myeloma research to share findings and improve treatment for everyone who has myeloma-related conditions. We are...

Study Link is here - (Originally published in the Journal of Clinical Oncology) We are grateful to our community of supporters in the...

Mark Bustoros, MD, discusses how the use of genomic predictors in multiple myeloma (MM) allows for a better understanding of who will...

Learn more about PCROWD and the ongoing research on precursor conditions. Video - 2:35 minutes In this interview with Mark Bustoros, MD...

Video: 30:34 Minutes A Professional Presentation From Dana-Farber Cancer Institute Mark Bustoros, MD of the Dana Farber Cancer Institute,...

VIDEO: 3:26 Minutes Even when people are not experiencing symptoms, it is important to consider the outcomes research when deciding...

BOSTON (CBS) – Fighting cancer one contribution at a time, that’s what’s happening Friday night on Channel 4 and on the other TV networks...

On September 7, Stand Up To Cancer’s (SU2C) telecast shared inspiring stories of hope, perseverance, and groundbreaking cancer research...

Ben Ebert is a physician and scientist focusing on the biology of leukemia and genetic mutations that cause cancers. He directs research...

CHICAGO – April 15, 2018 -- Stand Up To Cancer announced a $10 million award to a Stand Up To Cancer Dream Team focused on...

Mark Bustoros, MD, provides insight on prognostic models in smoldering multiple myeloma (SMM) and genetic mutations that are associated...

January 23, 2018 - Mark Bustoros, MD from Dana-Farber Cancer Institute discusses the Center for Prevention of Progression of Blood...

Mark Bustoros, MD from Dana-Farber Cancer Institute discusses on how to improve the prediction of progression of multiple myeloma at the...

Mark W. Bustoros, MD, a postdoctoral fellow at Dana-Farber Cancer Institute, Harvard Medical School, discusses ongoing research exploring...

In this video at ASH 2017, Irene Ghobrial, MD describes the research and recent discoveries that have been possible thanks to PCROWD...